{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:51:53Z","timestamp":1773661913230,"version":"3.50.1"},"reference-count":70,"publisher":"FapUNIFESP (SciELO)","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Approximately 71 million people are chronically infected with hepatitis C virus (HCV) worldwide. A significant number of these individuals will develop liver cirrhosis and\/or hepatocellular carcinoma. Beyond the liver, there is a sizeable body of scientific evidence linking cardiovascular disease and chronic hepatitis C (CHC); however, the biological mechanisms behind the concurrence of these conditions have not been completely clarified yet.  Objective: To evaluate associations between hepatic histology, clinical comorbidities and lipid profile in patients with CHC. To investigate associations between liver histology and demographic, nutritional, biochemical and virological parameters.  Methods: Eight-five patients with CHC prospectively underwent hepatic biopsy. Liver fragments were obtained from each patient by percutaneous route using a Menghini needle. Fibrosis was evaluated according to the METAVIR scoring system, as follows: F0, no fibrosis; F1, fibrous portal expansion; F2, fibrous portal widening with few septa; F3, bridging fibrosis with architectural distortion; and F4, liver cirrhosis. The activity was classified based on the degree of lymphocyte infiltration and hepatocyte necrosis, from A0 to A3. The diagnosis of liver disease was based on clinical, biochemical, histological, and radiological methods. The data were analyzed by logistic regression models.  Results: This cross-sectional study included 85 outpatients followed at the tertiary care ambulatory centre with a mean age of 57.2\u00b110.7 years and 45 (52.9%) were females. There were 10 patients with cirrhosis. Patients with a METAVIR F3-F4 were significantly older (P=0.02) and had higher levels of ALT (P=0.0006), AST (P&lt;0.0001), \u03b3-GT (P=0.03) and bilirubin (P=0.001) and higher prothrombin time than patients with F0-F2 score. Albumin levels (P=0.01) were significantly lower in METAVIR F3-F4. Age (OR=1.09; 95%CI=1.02-1.16; P=0.02), steatosis (OR=4.03; 95%CI=1.05-15.45; P=0.04) and high-density lipoprotein cholesterol (HDL-C) &lt;60 mg\/dL (OR=7.67; 95%CI=1.71-34.49; P=0.008) were independently associated with fibrosis. Hypertension (OR=6.36; 95%CI=1.31-30.85; P=0.02) and HDL-C &lt;60 mg\/dL (OR=9.85; 95%CI=2.35-41.39; P=0.002) were independently associated with necroinflammatory activity. Hypertension (OR=6.94; 95%CI=1.92-25.05; P=0.003) and HDL-C &lt;60 mg\/dL (OR=3.94; 95%CI=1.27-12.3; P=0.02) were associated with interface inflammatory activity. Triglycerides (TG \u2265150 mg\/dL) remained associated with lobular inflammatory activity.  Conclusion:  cholesterol levels &lt;60 mg\/dL were independently associated with necroinflammatory activity in chronic hepatitis C. Patients with hypertension are at an increased risk of developing necroinflammatory activity.<\/jats:p>","DOI":"10.1590\/s0004-2803.230302023-03","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:34:58Z","timestamp":1695641698000},"page":"287-299","source":"Crossref","is-referenced-by-count":4,"title":["HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND SYSTEMIC ARTERIAL HYPERTENSION ARE ASSOCIATED WITH HEPATIC NECROINFLAMMATORY ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C"],"prefix":"10.1590","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7354-1700","authenticated-orcid":false,"given":"Gustavo Henrique De Puy e","family":"SOUZA","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0061-7361","authenticated-orcid":false,"given":"Luciana Diniz","family":"SILVA","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil; Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6847-8068","authenticated-orcid":false,"given":"Diego Alves","family":"VIEIRA","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil; Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1858-3166","authenticated-orcid":false,"given":"Gifone Aguiar","family":"ROCHA","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6421-3062","authenticated-orcid":false,"given":"Agnaldo Soares","family":"LIMA","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7003-5159","authenticated-orcid":false,"given":"Paula Vieira Teixeira","family":"VIDIGAL","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(20)32111-5","article-title":"Nobel Prize for hepatitis C virus discoverers","volume":"396","author":"Burki T","year":"2020","journal-title":"Lancet"},{"key":"ref2","series-title":"Medicine Nobel honours three scientists for discoveries on hepatitis C virus"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4254\/wjh.v14.i6.1053","article-title":"Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection","volume":"14","author":"Salama II","year":"2022","journal-title":"World J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.gastro.2018.10.024","article-title":"Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges","volume":"156","author":"Baumert TF","year":"2019","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jvh.13218","article-title":"Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment","volume":"27","author":"Daniel KE","year":"2020","journal-title":"J Viral Hepat"},{"key":"ref6","series-title":"The authoritative resource for epidemiological data, modeling tools, training, and decision analytics to support global elimination of hepatitis B and C by 2030"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1007\/s42399-020-00588-3","article-title":"Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination","volume":"2","author":"Stasi C","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s40258-020-00623-3","article-title":"Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C","volume":"19","author":"Chen P","year":"2021","journal-title":"Appl Health Econ Health Policy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2020.07.042","article-title":"Impact of COVID-19 on global HCV elimination efforts","volume":"74","author":"Blach S","year":"2021","journal-title":"J Hepatol"},{"key":"ref11","year":"2017"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2000-9505","article-title":"Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome","volume":"20","author":"Alter HJ","year":"2000","journal-title":"Semin Liver Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1053\/j.gastro.2015.08.035","article-title":"Extrahepatic morbidity and mortality of chronic hepatitis C","volume":"149","author":"Negro F","year":"2015","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4254\/wjh.v12.i4.137","article-title":"Interleukin-6-174G\/C polymorphism is associated with a decreased risk of type 2 diabetes in patients with chronic hepatitis C virus","volume":"12","author":"da Silva CB","year":"2020","journal-title":"World J Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.3748\/wjg.v21.i36.10299","article-title":"Chronic hepatitis C virus infection and lipoprotein metabolism","volume":"21","author":"Aizawa Y","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/v5051292","article-title":"Hepatitis C virus, cholesterol and lipoproteins impact for the viral life cycle and pathogenesis of liver disease","volume":"5","author":"Felmlee DJ","year":"2013","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jhep.2018.11.033","article-title":"A serum protein factor mediates maturation and apoB-association of HCV particles in the extracellular milieu","volume":"70","author":"Denolly S","year":"2019","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"15975","DOI":"10.3748\/wjg.v20.i43.15975","article-title":"Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization","volume":"20","author":"Vercauteren K","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.3748\/wjg.v28.i22.2429","article-title":"Metabolic aspects of hepatitis C virus","volume":"28","author":"El-Kassas M","year":"2022","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"9942","DOI":"10.1038\/s41598-022-13657-5","article-title":"Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low-density lipoprotein-cholesterol","volume":"12","author":"Wang YK","year":"2022","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208839","article-title":"Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017)","volume":"13","author":"Badawi A","year":"2018","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/apt.15575","article-title":"Systematic review: chronic viral hepatitis and metabolic derangement","volume":"51","author":"Wang CC","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases","volume":"61","author":"Negro F","year":"2014","journal-title":"J Hepatol"},{"key":"ref24","article-title":"Direct-Acting Antiviral Therapy for HCV Infection Is Associated with a Reduced Risk of Cardiovascular Disease Events","volume":"156","author":"Butt AA","year":"2019","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2020-000470","article-title":"Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis C","volume":"7","author":"McPherson S","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejim.2019.03.004","article-title":"Hepatitis C virus infection and risk of coronary artery disease: A meta-analysis","volume":"63","author":"Wen D","year":"2019","journal-title":"Eur J Intern Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.3390\/jcm11144049","article-title":"Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Na\u00efve Patients without History of Cardiovascular Disease","volume":"11","author":"Casas-Deza D","year":"2022","journal-title":"J Clin Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.3748\/wjg.v25.i38.5826","article-title":"Hepatitis C virus clearance and less liver damage in patients with high cholesterol, low-density lipoprotein cholesterol and APOE\u03b54 allele","volume":"25","author":"Gonzalez-Aldaco K","year":"2019","journal-title":"World J Gastroenterol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3748\/wjg.15.1537","article-title":"Hepatitis C virus and type 2 diabetes","volume":"15","author":"Negro F","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0168-8278(01)00143-X","article-title":"Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C","volume":"35","author":"Petit JM","year":"2001","journal-title":"J Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White DL","year":"2008","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies","volume":"150","author":"Petta S","year":"2016","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jgh.12313","article-title":"Chronic hepatitis C infection is associated with insulin resistance and lipid profiles","volume":"30","author":"Dai CY","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.3748\/wjg.v21.i46.12989","article-title":"Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis","volume":"21","author":"Haga Y","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/jvh.13715","article-title":"Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver-related complications in patients with chronic hepatitis C receiving direct-acting antiviral agents","volume":"29","author":"Hsu WF","year":"2022","journal-title":"J Viral Hepat"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1590\/1516-4446-2014-1446","article-title":"Depression rather than liver impairment reduces quality of life in patients with hepatitis C","volume":"37","author":"Silva LD","year":"2015","journal-title":"Braz J Psychiatry"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.0126614100","article-title":"Color and genomic ancestry in Brazilians","volume":"100","author":"Parra FC","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Biggins SW","year":"2021","journal-title":"Hepatology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s P","year":"2021","journal-title":"Lancet"},{"key":"ref41","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child CG","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.21835","article-title":"Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review","volume":"46","author":"Shaheen AA","year":"2007","journal-title":"Hepatology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt EM","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","article-title":"Grading and staging systems for inflammation and fibrosis in chronic liver diseases","volume":"47","author":"Goodman ZD","year":"2007","journal-title":"J Hepatol"},{"key":"ref46","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo P","year":"2015","journal-title":"Gastroenterology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1080\/00952990.2018.1456545","article-title":"A review of the Alcohol Use Disorders Identification Test (AUDIT), AUDIT-C, and USAUDIT for screening in the United States: Past issues and future directions","volume":"44","author":"Higgins-Biddle JC","year":"2018","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli MF","year":"2016","journal-title":"Eur Heart J"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc14-S014","article-title":"Standards of medical care in diabetes - 2014","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone NJ","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"9N","DOI":"10.1016\/S0002-9149(01)02146-4","article-title":"Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease","volume":"88","author":"Franceschini G","year":"2001","journal-title":"Am J Cardiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon DJ","year":"1989","journal-title":"Circulation"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.ATV.0000094961.74697.54","article-title":"Endothelial protection by high-density lipoproteins: from bench to bedside","volume":"23","author":"Calabresi L","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in Atherosclerosis-No Longer a Theory","volume":"67","author":"Libby P","year":"2021","journal-title":"Clin Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMra2033539","article-title":"Extrahepatic Manifestations of Chronic HCV Infection","volume":"384","author":"Cacoub P","year":"2021","journal-title":"N Engl J Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"s26","DOI":"10.1111\/j.1478-3231.2008.01950.x","article-title":"Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data","volume":"29","author":"Negro F","year":"2009","journal-title":"Liver Int"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00281-012-0356-2","article-title":"Lipids and HCV","volume":"35","author":"Bassendine MF","year":"2013","journal-title":"Semin Immunopathol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biochi.2012.08.006","article-title":"Modified lipoproteins provide lipids that modulate dendritic cell immune function","volume":"95","author":"Perrin-Cocon L","year":"2013","journal-title":"Biochimie"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002260","article-title":"Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically infected by hepatitis C virus","volume":"3","author":"Perrin-Cocon L","year":"2008","journal-title":"PLoS One"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ni.2784","article-title":"High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3","volume":"15","author":"De Nardo D","year":"2014","journal-title":"Nat Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-8981(97)06532-7","article-title":"Blood lipids of patients with chronic hepatitis: differences related to viral aetiology","volume":"261","author":"Fabris C","year":"1997","journal-title":"Clin Chim Acta"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S1542-3565(04)00622-6","article-title":"High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics","volume":"3","author":"Habib A","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref63","first-page":"270","article-title":"Prognostic significance of clinical and laboratory parameters in liver cirrhosis. A multivariate statistical approach","volume":"32","author":"Milani A","year":"1985","journal-title":"Hepatogastroenterology"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jhep.2020.01.026","article-title":"HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure","volume":"73","author":"Trieb M","year":"2020","journal-title":"J Hepatol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani C","year":"1997","journal-title":"Arch Intern Med"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/clinchem\/28.3.525","article-title":"High-density lipoprotein cholesterol and phospholipids, and apoprotein A in serum of patients with liver disease","volume":"28","author":"Rubi\u00e9s-Prat J","year":"1982","journal-title":"Clin Chem"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1478-3231.2009.01973.x","article-title":"The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C","volume":"29","author":"Corey KE","year":"2009","journal-title":"Liver Int"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"G726","DOI":"10.1152\/ajpgi.00162.2009","article-title":"Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C","volume":"297","author":"Colmenero J","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref69","doi-asserted-by":"crossref","DOI":"10.21037\/tgh.2020.04.01","article-title":"Evolution of the liver biopsy and its future","volume":"6","author":"Jain D","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1590\/S1678-9946201658010","article-title":"Liver biopsy: importance of specimen size in the diagnosis and staging of chronic viral hepatitis","volume":"58","author":"Coral GP","year":"2016","journal-title":"Rev Inst Med Trop"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Lipoprote\u00edna de alta densidade e hipertens\u00e3o arterial sist\u00eamica est\u00e3o associados \u00e0 atividade necroinflamat\u00f3ria hep\u00e1tica em pacientes com hepatite C cr\u00f4nica"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032023000300287&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T11:35:37Z","timestamp":1695641737000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032023000300287&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["S0004-28032023000300287"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.230302023-03","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]}}}